G21R (p.Gly21Arg) variant of NPPA (Natriuretic peptides A)

G21R (p.Gly21Arg) in NPPA (Natriuretic peptides A) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.35 / 1. The record also includes population frequency data.

G21R (p.Gly21Arg) variant details